Single Ascending Dose Study in Participants With LCA10

Clinical trial NCT03872479 · UNKNOWN

Trial details

NCT number: NCT03872479
Sponsor: Editas Medicine, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leber Congenital Amaurosis 10 Inherited Retinal Dystrophies Eye Diseases, Hereditary Retinal Disease Retinal Degeneration Vision Disorders Eye Disorders Congenital

Start date: 2019-09-26
Primary completion: 2025-05-23
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.